885273-92-7 Usage
General Description
2-Methyl-5,6-dihydro-4H-pyrrolo[3,4-d]oxazole, also known as 4H-pyrrolo[3,4-d]oxazol-2-ylmethanamine, is a chemical compound with a molecular formula of C6H7NO. It is a heterocyclic compound with a fused oxazoline and pyrrole ring system, and it is often used in medicinal chemistry as a building block for the synthesis of various pharmaceutical compounds. Its structure and properties make it suitable for use in drug discovery and development, particularly in the field of neuroscience. Additionally, it has potential applications in the field of organic synthesis and as a tool compound for studying the activity of specific biological targets. Overall, 2-Methyl-5,6-dihydro-4H-pyrrolo[3,4-d]oxazole is a versatile chemical with important roles in pharmaceutical and scientific research.
Check Digit Verification of cas no
The CAS Registry Mumber 885273-92-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,5,2,7 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 885273-92:
(8*8)+(7*8)+(6*5)+(5*2)+(4*7)+(3*3)+(2*9)+(1*2)=217
217 % 10 = 7
So 885273-92-7 is a valid CAS Registry Number.
InChI:InChI=1/C6H8N2O/c1-4-8-5-2-7-3-6(5)9-4/h7H,2-3H2,1H3
885273-92-7Relevant articles and documents
HETEROBICYCLO-SUBSTITUTED-[1,2,4]TRIAZOLO[1,5-C]QUINAZOLIN-5-AMINE COMPOUNDS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDER
-
, (2014/07/21)
Disclosed are compounds of heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine herein, which have specific binding on an A2A-receptor and are useful for quantifying in vivo receptor-site occupancy of various compounds which have an affinity for binding to an A2A-receptor.
AMINOCYCLOHEXANES AS DIPEPTIDYL PEPTIDASE-IV INHIBITORS FOR THE TREATMENT OR PREVENTION OF DIABETES
-
Page/Page column 44, (2008/06/13)
The present invention is directed to novel substituted aminocyclohexanes of structural formula (I) which are inhibitors of the dipeptidyl peptidase-IV enzyme and which are useful in the treatment or prevention of diseases in which the dipeptidyl peptidase-IV enzyme is involved, such as diabetes and particularly Type 2 diabetes. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which the dipeptidyl peptidase-IV enzyme is involved.